Featured Articles
PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma
Natural plant antimicrobial solution alone or co-administration with low doses of temozolomide may be a potential adjuvant to reduce the toxicity of temozolomide and to evade drug resistance for the effective treatment of glioma.
Determining the antimicrobial activity of plant extracts and publishing the results
In this review one of our Section Editors, Jacobus Eloff, provides advice for researchers who wish to investigate the antimicrobial properties of plant derived extracts.
Spotlight On
High resolution biology
High-resolution imaging and genomic technologies are changing the way we view the environment, cells, chromosomes and molecules. Here we share recent highlights from the BMC Series journals.
Articles
-
-
Herbal Medicine (HM) among pharmacy professionals working in drug retail outlets in Asmara, Eritrea: knowledge, attitude and prevalence of use
-
Exploring in vitro anti-proliferative and anti-inflammatory activities of Prasachandaeng remedy, and its bioactive compounds
-
Traditional Chinese medicine formula 01 for nasopharyngeal carcinoma (NPC01) for head & neck cancer and health-related quality of life: a retrospective study
-
The effects of the ethanol extract of Cordia myxa leaves on the cognitive function in mice
-
In vitro antibacterial activity of some plant essential oils
-
Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity
-
Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice
-
Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L
-
Why people use herbal medicine: insights from a focus-group study in Germany
Aims and scope
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation.
About to Submit a Systematic Review?
BMC Complementary Medicine and Therapies is affiliated with Cochrane Complementary Medicine. The purpose of this affiliation is to improve the standard of Systematic Review reporting at the journal. Click the link below for an Editorial with more information on this partnership and how the journal treats Systematic Reviews.
Read MoreBMC Complementary Medicine and Therapies – we’ve updated our Research Standards
We are pleased to announce the new Research Standards for manuscripts submitted to BMC Complementary Medicine and Therapies. These changes renew the journal’s commitment to providing objective evidence for the efficacy or utilisation of complementary and alternative therapies. We will consider all manuscripts which meet these criteria. Click the button below to read more.
Read MoreBMC Series Blog
-
Highlights of the BMC Series – June 2022
22 July 2022
-
-
Highlights of the BMC Series – May 2022
21 June 2022
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline
Affiliated with
-
BMC Complementary Medicine and Therapies is affiliated with ISCMR, the international society for complementary medicine research and Cochrane Complementary Medicine
Follow
Annual Journal Metrics
-
Citation Impact
For BMC Complementary and Alternative Medicine (former title)
2.838 - 2-year Impact Factor (2021)
2.838 - 5-year Impact Factor (2021)
1.471 - SNIP (Source Normalized Impact per Paper)
0.674 - SJR (SCImago Journal Rank)Speed
3 days to first decision for all manuscripts (Median)
186 days to first decision for reviewed manuscripts only (Median)Usage
3,053,194 downloads (2021)
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication